jkuil
14th April 2008, 06:03 AM
In the latest amendment of the Directive (2007/47/EC) the following was added to Annex II 3.2c:
“where the design, manufacture and/or final inspection and testing of the products, or elements thereof, is carried out by a third party, the methods of monitoring the efficient operation of the quality system and in particular the type and extent of control applied to the third party”
I am working at a Medical Device facility, which will become a virtual manufacturer. This means that we are registered as the legal labelled manufacturer for the products but the design, development, manufacturing, labeling, and packaging will be carried out by other legal entities of our franchise. We do have the same quality system. What methods of monitoring the efficient operation of the quality system and in particular the type and extent of control should be applied to our sister companies?
“where the design, manufacture and/or final inspection and testing of the products, or elements thereof, is carried out by a third party, the methods of monitoring the efficient operation of the quality system and in particular the type and extent of control applied to the third party”
I am working at a Medical Device facility, which will become a virtual manufacturer. This means that we are registered as the legal labelled manufacturer for the products but the design, development, manufacturing, labeling, and packaging will be carried out by other legal entities of our franchise. We do have the same quality system. What methods of monitoring the efficient operation of the quality system and in particular the type and extent of control should be applied to our sister companies?





